Cite
MLA Citation
B. Glintborg et al.. “OP0225 Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry.” Annals of the rheumatic diseases, vol. 75, n.d., p. 142. http://access.bl.uk/ark:/81055/vdc_100135123350.0x000051